Analyst Consensus ?
ConsensusBuy29 ratings
Bullish1965.5%
Neutral1034.5%
Bearish00.0%
AMETEK, Inc. · AME · FY2026 Q3 · Calendar Q4 2026
AMETEK raises FY2026 outlook after record Q3 and stronger orders
The Q3 account supports a constructive operating picture: record results, stronger orders and a raised full-year outlook extend the momentum reported in Q2. The thesis depends on demand converting from backlog into revenue while AMETEK sustains margins and executes Indicor integration amid leverage and macroeconomic risks.
Reported Before market openNYSEIndustrials
$55.46B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $2.11
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $2.12B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+2.8%
Event window
SPY move
+0.3%
Same window
Abnormal move
+2.5%
Stock minus SPY
Volume
1.6×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
AMESPY benchmark
Ask FN2 about AME FY2026 Q3
Transcript, numbers and history already loaded
What drove AME's +2.8% move after FY2026 Q3 earnings?What changed in AME's guidance and outlook in FY2026 Q3?Give me the bull and bear case for AME after FY2026 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with Q2, management reported record Q3 performance, 35% year-over-year order growth and a record $4.54 billion backlog, with 80% considered shippable within 12 months. It raised full-year sales, EPS and cash-flow guidance again. Indicor is contributing to results and is reported as integrating well, while DPP+ expands the product lineup.
Guidance delta
Raised full-year 2026 sales, EPS and cash-flow guidance; the supplied current-quarter analysis gives EPS guidance of $8.53–$8.57. Prior-quarter guidance had also been raised, to EPS of $8.20–$8.30.
Key takeaways
- Q3 sales reached $2.22 billion, up 17% year over year, with double-digit organic growth, according to the supplied transcript analysis.
- Orders rose 35% year over year and backlog reached $4.54 billion; management considers 80% shippable within 12 months.
- Operating margins improved, free cash flow reached a record $527 million, and management raised full-year guidance.
Management priorities
- Integrate Indicor and pursue the stated 10–12% synergies over three years.
- Continue investment in R&D, new products and growth markets, including AI, power and med-tech.
- Maintain capital investment of about $160 million for the year, as stated in the supplied analysis.
Follow AME with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$248.58Current
$135Low
$243.78Average
$316High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 4, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Neutral | Neutral | Maintain | Oct 12, 2026 |
| Baird | Neutral | Neutral | Maintain | Oct 5, 2026 |
| BNP Paribas | Outperform | Outperform | Maintain | Sep 11, 2026 |
| Truist Securities | Buy | Buy | Maintain | Aug 6, 2026 |
| TD Cowen | Buy | Buy | Maintain | Aug 6, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 5, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Aug 5, 2026 |
| DA Davidson | Buy | Buy | Maintain | Aug 5, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 5, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 10, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 4, 2026 |
| Oppenheimer | Perform | Outperform | Downgrade | Jan 27, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jan 5, 2026 |
| B of A Securities | Buy | Neutral | Upgrade | Dec 16, 2024 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 2, 2023 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Feb 23, 2023 |
| Loop Capital | Buy | Buy | Maintain | Jul 19, 2022 |
| Rosenblatt | Buy | Buy | Maintain | Aug 4, 2021 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Mar 12, 2020 |
| Stephens & Co. | Overweight | Overweight | Maintain | Feb 7, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Oct 11, 2019 |
| Jefferies | Buy | Buy | Maintain | Oct 13, 2017 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Feb 15, 2017 |
| Stifel Nicolaus | Buy | Buy | Maintain | Aug 5, 2016 |
| Stifel | Buy | Buy | Maintain | Aug 5, 2016 |
| Deutsche Bank | Hold | Hold | Maintain | Jan 7, 2013 |
| UBS | Neutral | Neutral | Maintain | Oct 31, 2012 |
| Ladenburg Thalmann | Buy | Hold | Upgrade | Jul 24, 2012 |
| Langenberg & Company | Hold | Buy | Downgrade | Apr 27, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $248.58. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Christopher Snyder | $275 | $248.82 | +10.6% | Oct 9, 2026 |
| D.A. Davidson | Matt Summerville | $285 | $247.9 | +14.7% | Oct 7, 2026 |
| Vertical Research | Analyst unavailable | $255 | $237.72 | +2.6% | Sep 8, 2026 |
| Truist Financial | Analyst unavailable | $316 | $255.23 | +27.1% | Aug 6, 2026 |
| Seaport Global | Scott Graham | $290 | $255.81 | +16.7% | Aug 5, 2026 |
| RBC Capital | Deane Dray | $291 | $254.5 | +17.1% | Aug 5, 2026 |
| Robert W. Baird | Quinn Fredrickson | $275 | $254.05 | +10.6% | Aug 5, 2026 |
| KeyBanc | Analyst unavailable | $295 | $254.05 | +18.7% | Aug 5, 2026 |
| Morgan Stanley | Analyst unavailable | $245 | $234.99 | -1.4% | Jul 10, 2026 |
| Truist Financial | Jamie Cook | $303 | $237.13 | +21.9% | Jul 2, 2026 |
| Redburn Partners | Richard Radbourne | $265 | $231.27 | +6.6% | Jun 18, 2026 |
| Truist Financial | Analyst unavailable | $275 | $231.3 | +10.6% | May 4, 2026 |
| Barclays | Julian Mitchell | $230 | $230.48 | -7.5% | May 4, 2026 |
| Robert W. Baird | Quinn Fredrickson | $244 | $231.98 | -1.8% | May 1, 2026 |
| Mizuho Securities | Analyst unavailable | $270 | $232.62 | +8.6% | May 1, 2026 |
| BMO Capital | Daniel DiCicco | $253 | $211.47 | +1.8% | Mar 26, 2026 |
| Robert W. Baird | Analyst unavailable | $245 | $227.83 | -1.4% | Feb 5, 2026 |
| Truist Financial | Analyst unavailable | $265 | $229.46 | +6.6% | Feb 4, 2026 |
| RBC Capital | Analyst unavailable | $257 | $227.97 | +3.4% | Feb 4, 2026 |
| Mizuho Securities | Analyst unavailable | $235 | $228.92 | -5.5% | Feb 4, 2026 |
| Barclays | Julian Mitchell | $220 | $228.92 | -11.5% | Feb 4, 2026 |
| Deutsche Bank | Analyst unavailable | $271 | $213.14 | +9.0% | Jan 21, 2026 |
| Morgan Stanley | Christopher Snyder | $215 | $211.1 | -13.5% | Jan 12, 2026 |
| Barclays | Julian Mitchell | $210 | $214.16 | -15.5% | Jan 7, 2026 |
| KeyBanc | Analyst unavailable | $235 | $211.31 | -5.5% | Jan 6, 2026 |
| Melius Research | Rob Wertheimer | $235 | $212.09 | -5.5% | Jan 5, 2026 |
| Mizuho Securities | Analyst unavailable | $230 | $209.14 | -7.5% | Jan 5, 2026 |
| D.A. Davidson | Analyst unavailable | $240 | $199.92 | -3.5% | Dec 8, 2025 |
| Robert W. Baird | Richard Eastman | $204 | $202.11 | -17.9% | Nov 3, 2025 |
| Seaport Global | Analyst unavailable | $240 | $199.96 | -3.5% | Oct 31, 2025 |
| RBC Capital | Deane Dray | $229 | $198.84 | -7.9% | Oct 31, 2025 |
| KeyBanc | Analyst unavailable | $220 | $198.32 | -11.5% | Oct 31, 2025 |
| Barclays | Analyst unavailable | $205 | $198.32 | -17.5% | Oct 31, 2025 |
| Truist Financial | Jamie Cook | $229 | $181.42 | -7.9% | Oct 8, 2025 |
| Mizuho Securities | Brett Linzey | $212 | $182.75 | -14.7% | May 16, 2025 |
| Truist Financial | Jamie Cook | $219 | $166.92 | -11.9% | Oct 9, 2024 |
| Oppenheimer | Christopher Glynn | $190 | $163.9 | -23.6% | Sep 10, 2024 |
| Seaport Global | Scott Graham | $200 | $154 | -19.5% | Aug 2, 2024 |
| Truist Financial | Jamie Cook | $204 | $165.57 | -17.9% | Jul 2, 2024 |
| Oppenheimer | Christopher Glynn | $200 | $169.13 | -19.5% | May 22, 2024 |
| Seaport Global | Scott Graham | $208 | $168.06 | -16.3% | May 6, 2024 |
| Robert W. Baird | Richard Eastman | $171 | $166.56 | -31.2% | May 6, 2024 |
| RBC Capital | Deane Dray | $216 | $179.34 | -13.1% | Apr 4, 2024 |
| Truist Financial | Jamie Cook | $210 | $181.53 | -15.5% | Mar 13, 2024 |
| Morgan Stanley | Analyst unavailable | $152 | $142.36 | -38.9% | Jan 6, 2023 |
| Mizuho Securities | Brett Linzey | $140 | $129.31 | -43.7% | Aug 15, 2022 |
| Morgan Stanley | Analyst unavailable | $145 | $126.04 | -41.7% | Aug 3, 2022 |
| RBC Capital | Analyst unavailable | $135 | $125.85 | -45.7% | Aug 3, 2022 |
| Loop Capital Markets | Analyst unavailable | $155 | $109.1 | -37.6% | Jul 19, 2022 |
| Mizuho Securities | Analyst unavailable | $135 | $110.92 | -45.7% | Jul 18, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $135 | $121.86 | -45.7% | Jun 3, 2022 |
| Morgan Stanley | Analyst unavailable | $144 | $124.06 | -42.1% | May 4, 2022 |
| RBC Capital | Analyst unavailable | $148 | $124.31 | -40.5% | May 4, 2022 |
| KeyBanc | Steve Barger | $145 | $124.31 | -41.7% | May 4, 2022 |
| D.A. Davidson | Matt Summerville | $160 | $138.12 | -35.6% | Aug 3, 2021 |
Track every rating change on AME the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationAMETEK, Inc. is a global enterprise that develops and markets a diverse portfolio of electronic instruments and electromechanical devices. The company's operations are structured into two principal divisions: the Electronic Instruments Group (EIG) and the Electromechanical Group (EMG). The EIG segment provides sophisticated instrumentation solutions catering to various sectors, including process control, aerospace, power generation, and general industrial applications. It also delivers specialized process and analytical tools essential for industries such as oil and gas, petrochemicals, pharmaceuticals, semiconductors, automation, and food and beverage production. Furthermore, EIG supplies equipment for laboratory settings, ultra-precision manufacturing, medical diagnostics, and critical test and measurement tasks.…
Historical context
All AME earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ETN Eaton Corporation plc | FY2026 Q3 · Calendar Q4 2026 | — | +7.0% | Eaton raises 2026 outlook as electrical backlog and data-center orders grow |
| RRX Regal Rexnord Corporation | FY2026 Q3 · Calendar Q4 2026 | +41.1% | +11.8% | Regal Rexnord Raises 2026 Outlook as Plant Execution Remains a Risk |
| TRI Thomson Reuters Corporation | FY2026 Q3 · Calendar Q4 2026 | — | -7.3% | Thomson Reuters lifts FY outlook as AI products support Q3 growth |
| ULS UL Solutions Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +9.8% | UL Solutions lifts FY2026 outlook as organic growth accelerates |
Latest beats and misses
Who reports nextBeat on EPS
- FANGFY2026 Q3 · November 2, 2026+2.4% EPS-3.7% move
- RRXFY2026 Q3 · November 3, 2026+41.1% EPS+11.8% move
- UDRFY2026 Q3 · November 2, 2026+340.8% EPS+0.1% move
- VNOMFY2026 Q3 · November 2, 2026+3.9% EPS-2.6% move
- EQH-PAFY2026 Q3 · November 2, 2026+14.5% EPS— move
- WMBFY2026 Q3 · November 2, 2026+0.2% EPS+3.5% move
Get the AME recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-11-03T18:07:03.800879+00:00
- FN2 earnings calendar · 2026-11-03T01:23:13.143323+00:00
- Polygon adjusted daily market bars · 2026-11-03T23:00:48.853634+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-03T23:00:48.851004+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-03. For educational purposes only; not investment advice.